Novavax, Inc.

Informe acción NasdaqGS:NVAX

Capitalización de mercado: US$1.2b

Novavax Dirección

Dirección controles de criterios 1/4

El CEO de Novavax es John Jacobs , nombrado en Jan 2023, tiene una permanencia de 1.83 años. compensación anual total es $7.30M, compuesta por 9.1% salario y 90.9% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.03% de las acciones de la empresa, por valor de $347.90K. La antigüedad media del equipo directivo y de la junta directiva es de 1.8 años y 4.3 años, respectivamente.

Información clave

John Jacobs

Chief Executive Officer (CEO)

US$7.3m

Compensación total

Porcentaje del salario del CEO9.1%
Permanencia del CEO1.8yrs
Participación del CEO0.03%
Permanencia media de la dirección1.8yrs
Promedio de permanencia en la Junta Directiva4.3yrs

Actualizaciones recientes de la dirección

Recent updates

Novavax, Inc. (NASDAQ:NVAX) Just Reported, And Analysts Assigned A US$16.67 Price Target

Nov 15
Novavax, Inc. (NASDAQ:NVAX) Just Reported, And Analysts Assigned A US$16.67 Price Target

Novavax Q3 Earnings Disappoint, But A Turnaround May Be Underway

Nov 13

Novavax, Inc.'s (NASDAQ:NVAX) 35% Dip In Price Shows Sentiment Is Matching Revenues

Nov 01
Novavax, Inc.'s (NASDAQ:NVAX) 35% Dip In Price Shows Sentiment Is Matching Revenues

Novavax Q3 Earnings A Week Away - Time To Accept A New Reality

Oct 31

Novavax's Future Hinges On Sanofi Deal And Upcoming Milestones

Sep 01

Novavax, Inc.'s (NASDAQ:NVAX) Shares Lagging The Industry But So Is The Business

Aug 14
Novavax, Inc.'s (NASDAQ:NVAX) Shares Lagging The Industry But So Is The Business

Novavax: Staying Long Despite Coming Up Short In Q2

Aug 13

Novavax Ahead Of Q2 Earnings - Picking Apart The Sanofi Deal

Jul 26

Novavax: New Chapter, Questions Remain

Jun 20

Novavax, Inc. (NASDAQ:NVAX) Surges 206% Yet Its Low P/S Is No Reason For Excitement

May 14
Novavax, Inc. (NASDAQ:NVAX) Surges 206% Yet Its Low P/S Is No Reason For Excitement

Novavax, Inc. (NASDAQ:NVAX) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates

May 13
Novavax, Inc. (NASDAQ:NVAX) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates

Novavax Q1 2024 Earnings Preview: Success In New Commercial COVID Markets Unlikely

May 07

Novavax: Another Day Older And Deeper In

Mar 02

Novavax, Inc.'s (NASDAQ:NVAX) Shares Bounce 35% But Its Business Still Trails The Industry

Mar 02
Novavax, Inc.'s (NASDAQ:NVAX) Shares Bounce 35% But Its Business Still Trails The Industry

Earnings Update: Here's Why Analysts Just Lifted Their Novavax, Inc. (NASDAQ:NVAX) Price Target To US$22.00

Mar 01
Earnings Update: Here's Why Analysts Just Lifted Their Novavax, Inc. (NASDAQ:NVAX) Price Target To US$22.00

Novavax Q4 Earnings Preview: Settlement With Gavi Doesn't Solve Problems

Feb 23

Investors Don't See Light At End Of Novavax, Inc.'s (NASDAQ:NVAX) Tunnel

Sep 06
Investors Don't See Light At End Of Novavax, Inc.'s (NASDAQ:NVAX) Tunnel

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de John Jacobs en comparación con los beneficios de Novavax?
FechaCompensación totalSalarioIngresos de la empresa
Sep 30 2024n/an/a

-US$285m

Jun 30 2024n/an/a

-US$294m

Mar 31 2024n/an/a

-US$399m

Dec 31 2023US$7mUS$663k

-US$545m

Compensación vs. Mercado: La compensación total de John($USD7.30M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD3.20M).

Compensación vs. Ingresos: Datos insuficientes para comparar la compensación de John con los resultados de la empresa.


CEO

John Jacobs (57 yo)

1.8yrs

Permanencia

US$7,301,009

Compensación

Mr. John Charles Jacobs, M.B.A., serves as Chief Executive Officer and Director of Novavax, Inc. since January 23, 2023 and serves as its President from January 23, 2023. He was Director of Life Sciences P...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
John Jacobs
President1.8yrsUS$7.30m0.030%
$ 347.9k
John Trizzino
President & COOless than a yearUS$1.88m0.018%
$ 207.2k
James Kelly
Executive VP3.3yrsUS$1.50m0.0090%
$ 105.6k
Mark Casey
Executive VPless than a yearUS$1.53msin datos
Richard Crowley
Executive VP & COO1.8yrssin datossin datos
Robert Walker
Senior VPless than a yearsin datossin datos
Troy Morgan
Senior VPno datasin datossin datos
Erika Trahan
Associate Director of Investor & Public Relations6.6yrssin datossin datos
Ian Watkins
Executive VP & Chief Human Resources Officer1.3yrssin datossin datos
Silvia Taylor
Executive VP and Chief Corporate Affairs & Advocacy Officer2.8yrssin datossin datos
Elaine O'Hara
Executive VP & Chief Strategy Officer1.8yrssin datos0.0089%
$ 104.1k

1.8yrs

Permanencia media

59.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de NVAX no se considera experimentado ( 1.8 años antigüedad media), lo que sugiere un nuevo equipo.


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
John Jacobs
President1.8yrsUS$7.30m0.030%
$ 347.9k
David Mott
Independent Director4.4yrsUS$187.53k0.032%
$ 369.5k
Richard Douglas
Independent Director14.8yrsUS$189.53k0.027%
$ 321.5k
Margaret McGlynn
Independent Director3.9yrsUS$185.02k0.0065%
$ 76.7k
Gregg Alton
Independent Director4.1yrsUS$175.28k0.0065%
$ 76.7k
Rachel King
Independent Director6yrsUS$174.55k0.012%
$ 138.5k
Richard Rodgers
Independent Director2.1yrsUS$191.78k0.0065%
$ 76.7k
James Young
Independent Chairman of the Board14.6yrsUS$222.53k0.039%
$ 452.1k

4.3yrs

Permanencia media

62yo

Promedio de edad

Junta con experiencia: La junta directiva de NVAX se considera experimentada (4.3 años de antigüedad promedio).